These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22491493)

  • 21. The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus.
    Girardet A; Viart V; Plaza S; Daina G; De Rycke M; Des Georges M; Fiorentino F; Harton G; Ishmukhametova A; Navarro J; Raynal C; Renwick P; Saguet F; Schwarz M; SenGupta S; Tzetis M; Roux AF; Claustres M
    Eur J Hum Genet; 2016 Apr; 24(4):469-78. PubMed ID: 26014425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal potential difference in cystic fibrosis considering severe CFTR mutations.
    Ng RT; Marson FA; Ribeiro JD; Ribeiro AF; Bertuzzo CS; Ribeiro MA; Severino SD; Sakano E
    Dis Markers; 2015; 2015():306825. PubMed ID: 25667564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demographic, clinical, and laboratory parameters of cystic fibrosis during the last two decades: a comparative analysis.
    Marson FA; Hortencio TD; Aguiar KC; Ribeiro JD;
    BMC Pulm Med; 2015 Jan; 15():3. PubMed ID: 25592785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.
    Seegmiller AC
    Int J Mol Sci; 2014 Sep; 15(9):16083-99. PubMed ID: 25216340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annotating DNA variants is the next major goal for human genetics.
    Cutting GR
    Am J Hum Genet; 2014 Jan; 94(1):5-10. PubMed ID: 24387988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis.
    Coutinho CA; Marson FA; Ribeiro AF; Ribeiro JD; Bertuzzo CS
    J Bras Pneumol; 2013; 39(5):555-61. PubMed ID: 24310628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene.
    Sosnay PR; Siklosi KR; Van Goor F; Kaniecki K; Yu H; Sharma N; Ramalho AS; Amaral MD; Dorfman R; Zielenski J; Masica DL; Karchin R; Millen L; Thomas PJ; Patrinos GP; Corey M; Lewis MH; Rommens JM; Castellani C; Penland CM; Cutting GR
    Nat Genet; 2013 Oct; 45(10):1160-7. PubMed ID: 23974870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expectations and values about expanded newborn screening: a public engagement study.
    Hayeems RZ; Miller FA; Bombard Y; Avard D; Carroll J; Wilson B; Little J; Chakraborty P; Bytautas J; Giguere Y; Allanson J; Axler R
    Health Expect; 2015 Jun; 18(3):419-29. PubMed ID: 23369110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis carrier screening.
    Massie J; Delatycki MB
    Paediatr Respir Rev; 2013 Dec; 14(4):270-5. PubMed ID: 23466339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening for cystic fibrosis.
    Wagener JS; Zemanick ET; Sontag MK
    Curr Opin Pediatr; 2012 Jun; 24(3):329-35. PubMed ID: 22491493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive neonatal screening for cystic fibrosis in neonates with renal failure.
    Oosterveld MJ; Schilperoort JV; Lilien MR; Arets HG
    Thorax; 2010 Jul; 65(7):652-3. PubMed ID: 20627926
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.